Section 1 Prohibition on use of Federal and local funds to impose or enforce COVID–19 vaccine mandate in District of Columbia schools
Definitions— In this section:
Covered school— The term covered school means an elementary school or a secondary school, as those terms are defined in section 8101 of the Elementary and Secondary Education Act of 1965 (20 U.S.C. 7801), in the District of Columbia.
COVID–19 vaccine— The term COVID–19 vaccine means any vaccine for the prevention of Coronavirus Disease 2019 (COVID–19) caused by severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) that is approved under section 351 of the Public Health Service Act (42 U.S.C. 262) or section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) or authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3).
Prohibition— No Federal or local funds may be used by the District of Columbia or a covered school to impose or enforce a COVID–19 vaccine requirement on a student in connection with enrollment by the student in a covered school, including any requirement that a student receive a COVID–19 vaccine in order to be able to attend in-person classroom instruction or participate in any school-related activity on or off campus, including an athletic or academic competition.